. 2022 Jul 22;2022:6530454. doi: 10.1155/2022/6530454

Table 2.

RPFS-CV scores of three groups of patients.

Group	T1	T8	T12	T21
Control	1.57 ± 0.73	2.16 ± 0.76^a	2.23 ± 0.77^a	2.63 ± 0.79^abc
Mild moxibustion	1.55 ± 0.73	1.74 ± 0.74^∗^#a	1.84 ± 0.71^∗^#a	2.08 ± 0.83^∗^#abc
Sham acupoint	1.62 ± 0.62	2.00 ± 0.73^a	2.13 ± 0.61^a	2.49 ± 0.74^abc

Note: T1: 1 day before chemotherapy; T8: the 8th day of chemotherapy; T12: the 12th day of chemotherapy; T21: the 21st day of chemotherapy. ^aDifference compared with T1; ^bdifference compared with T8; ^cdifference compared with T21; ^∗difference compared with the control group; ^#difference compared with the sham acupoint group.